Mates Sharon
Insider CIK 1585699 · ITCI Chairman, President & CEO, Director · BNTC Director · SPTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPTX Seaport Therapeutics, Inc. | A Award deriv | 2026-04-30 | 2026-05-04 | 49,033 | — | $0 | 49,033 | SEC↗ |
| BNTC Benitec Biopharma Inc. | A Award deriv | 2026-01-22 | 2026-01-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| BNTC Benitec Biopharma Inc. | A Award deriv | 2025-12-01 | 2025-12-03 | 3,500 | — | $0 | 3,500 | SEC↗ |
| BNTC Benitec Biopharma Inc. | A Award deriv | 2025-11-05 | 2025-11-07 | 28,517 | — | $0 | 28,517 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 69,940 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 34,970 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 135,399 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 138,473 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 66,886 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 53,471 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 50,167 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 40,713 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 86,003 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 121,212 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 40,712 | — | $0 | 40,712 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 40,712 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 34,970 | — | $0 | 34,970 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer | 2025-04-02 | 2025-04-02 | 945,235 | $132.00 | $124.77M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer | 2025-04-02 | 2025-04-02 | 190,000 | $132.00 | $25.08M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | G Gift | 2025-03-26 | 2025-03-31 | 190,000 | — | $0 | 190,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | G Gift | 2025-03-26 | 2025-03-31 | 190,000 | — | $0 | 945,235 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-10 | 2025-03-10 | 20,566 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-10 | 2025-03-10 | 20,566 | — | $0 | 1,145,364 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-10 | 2025-03-10 | 10,129 | $131.24 | $1.33M | 1,135,235 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-06 | 2025-03-10 | 40,712 | — | $0 | 40,713 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-06 | 2025-03-10 | 19,848 | $131.19 | $2.60M | 1,124,798 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-06 | 2025-03-10 | 40,712 | — | $0 | 1,144,646 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-01 | 2025-03-04 | 34,969 | — | $0 | 69,940 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-01 | 2025-03-04 | 16,978 | $128.20 | $2.18M | 1,103,934 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-01 | 2025-03-04 | 34,969 | — | $0 | 1,120,912 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-02-03 | 2025-02-04 | 121,212 | — | $0 | 121,212 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2025-01-31 | 2025-02-04 | 30,847 | — | $0 | 1,101,176 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-01-31 | 2025-02-04 | 15,233 | $127.00 | $1.93M | 1,085,943 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-12-05 | 2024-12-06 | 51,697 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-12-05 | 2024-12-06 | 1,534 | $84.69 | $129.9K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-12-05 | 2024-12-06 | 50,163 | $84.06 | $4.22M | 1,071,863 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-12-05 | 2024-12-06 | 51,697 | $12.73 | $658.1K | 1,122,026 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-12-04 | 2024-12-06 | 51,000 | — | $0 | 51,697 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-12-04 | 2024-12-06 | 51,000 | $12.73 | $649.2K | 1,121,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-12-04 | 2024-12-06 | 27,667 | $85.62 | $2.37M | 1,093,662 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-12-04 | 2024-12-06 | 23,333 | $86.00 | $2.01M | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-30 | 2024-08-30 | 34,396 | — | $0 | 102,697 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-30 | 2024-08-30 | 34,396 | $12.73 | $437.9K | 1,104,725 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-30 | 2024-08-30 | 28,203 | $72.73 | $2.05M | 1,076,522 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-30 | 2024-08-30 | 6,193 | $73.32 | $454.1K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-29 | 2024-08-30 | 35,604 | — | $0 | 137,093 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-29 | 2024-08-30 | 35,604 | $12.73 | $453.2K | 1,105,933 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-29 | 2024-08-30 | 29,832 | $72.44 | $2.16M | 1,076,101 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-29 | 2024-08-30 | 5,772 | $73.25 | $422.8K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-28 | 2024-08-28 | 32,699 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-28 | 2024-08-28 | 240 | $73.70 | $17.7K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-28 | 2024-08-28 | 32,459 | $72.74 | $2.36M | 1,070,569 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-28 | 2024-08-28 | 32,699 | $17.57 | $574.5K | 1,103,028 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-27 | 2024-08-28 | 40,513 | — | $0 | 32,699 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-27 | 2024-08-28 | 16,856 | $73.93 | $1.25M | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-27 | 2024-08-28 | 23,657 | $73.33 | $1.73M | 1,087,185 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-27 | 2024-08-28 | 40,513 | $17.57 | $711.8K | 1,110,842 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-26 | 2024-08-28 | 22,713 | — | $0 | 73,212 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-26 | 2024-08-28 | 22,713 | $17.57 | $399.1K | 1,093,042 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-26 | 2024-08-28 | 22,713 | $74.59 | $1.69M | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-23 | 2024-08-23 | 28,680 | — | $0 | 95,925 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-23 | 2024-08-23 | 28,680 | $17.57 | $503.9K | 1,099,009 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-23 | 2024-08-23 | 28,680 | $74.46 | $2.14M | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-22 | 2024-08-23 | 39,380 | — | $0 | 124,605 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-22 | 2024-08-23 | 39,380 | $17.57 | $691.9K | 1,109,709 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-22 | 2024-08-23 | 35,011 | $74.58 | $2.61M | 1,074,698 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-22 | 2024-08-23 | 4,369 | $75.47 | $329.7K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-21 | 2024-08-23 | 53,013 | — | $0 | 163,985 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-21 | 2024-08-23 | 4,297 | $76.20 | $327.4K | 1,074,911 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-21 | 2024-08-23 | 53,013 | $17.57 | $931.4K | 1,123,342 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-21 | 2024-08-23 | 44,134 | $75.40 | $3.33M | 1,079,208 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-21 | 2024-08-23 | 2,682 | $77.21 | $207.1K | 1,072,229 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-21 | 2024-08-23 | 1,900 | $77.98 | $148.2K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-04-24 | 2024-04-25 | 8,638 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-04-24 | 2024-04-25 | 11,382 | — | $0 | 216,998 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-04-24 | 2024-04-25 | 8,638 | $16.86 | $145.6K | 1,058,947 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-04-24 | 2024-04-25 | 11,382 | $17.57 | $200.0K | 1,070,329 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 1,590 | $66.81 | $106.2K | 1,050,615 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 4,128 | $65.90 | $272.0K | 1,052,205 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 14,541 | $64.80 | $942.3K | 1,056,333 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 306 | $67.33 | $20.6K | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-10 | 2024-03-11 | 20,565 | — | $0 | 20,566 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-10 | 2024-03-11 | 20,565 | — | $0 | 1,070,874 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 31,958 | $66.38 | $2.12M | 1,059,063 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 8,754 | $66.93 | $585.9K | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-06 | 2024-03-08 | 40,712 | — | $0 | 81,425 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-06 | 2024-03-08 | 40,712 | — | $0 | 1,091,021 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2024-03-01 | 2024-03-05 | 104,909 | — | $0 | 104,909 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 9,528 | $69.45 | $661.7K | 1,062,771 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 12,462 | $70.11 | $873.7K | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 600 | $68.39 | $41.0K | 1,072,299 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-02-23 | 2024-02-27 | 22,590 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-02-23 | 2024-02-27 | 22,590 | — | $0 | 1,072,899 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 17,450 | $67.42 | $1.18M | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 16,435 | $66.70 | $1.10M | 1,067,759 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2024-02-01 | 2024-02-05 | 33,885 | — | $0 | 1,084,194 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-01-18 | 2024-01-18 | 67,917 | — | $0 | 8,638 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-01-18 | 2024-01-18 | 67,917 | $16.86 | $1.15M | 1,118,226 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-18 | 2024-01-18 | 67,597 | $65.19 | $4.41M | 1,050,629 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-18 | 2024-01-18 | 320 | $66.25 | $21.2K | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-01-17 | 2024-01-18 | 48,084 | — | $0 | 76,555 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-17 | 2024-01-18 | 17,451 | $66.66 | $1.16M | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-01-17 | 2024-01-18 | 48,084 | $16.86 | $810.7K | 1,098,393 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-17 | 2024-01-18 | 30,633 | $66.00 | $2.02M | 1,067,760 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-01-16 | 2024-01-18 | 75,361 | — | $0 | 124,639 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-01-16 | 2024-01-18 | 75,361 | $16.86 | $1.27M | 1,125,670 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-16 | 2024-01-18 | 3,500 | $66.38 | $232.3K | 1,122,170 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-16 | 2024-01-18 | 65,979 | $67.25 | $4.44M | 1,056,191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-16 | 2024-01-18 | 5,882 | $67.76 | $398.6K | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-09-19 | 2023-09-19 | 44,413 | $54.17 | $2.41M | 1,050,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-09-18 | 2023-09-19 | 27,468 | $53.55 | $1.47M | 1,122,841 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-09-18 | 2023-09-19 | 28,119 | $53.96 | $1.52M | 1,094,722 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-03-13 | 2023-03-13 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 1,412 | $44.08 | $62.2K | 1,130,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 19,153 | $45.06 | $863.0K | 1,131,721 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-03-13 | 2023-03-13 | 20,000 | $3.26 | $65.2K | 1,150,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-03-10 | 2023-03-13 | 20,565 | — | $0 | 41,131 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-03-10 | 2023-03-13 | 20,565 | — | $0 | 1,150,874 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 6,805 | $42.51 | $289.3K | 1,130,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 34,965 | $43.28 | $1.51M | 1,137,114 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-03-09 | 2023-03-13 | 41,770 | — | $0 | 1,172,079 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2023-03-06 | 2023-03-08 | 122,137 | — | $0 | 122,137 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-24 | 2023-02-27 | 30,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-24 | 2023-02-27 | 22,590 | $47.03 | $1.06M | 1,100,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-24 | 2023-02-27 | 30,000 | $3.26 | $97.8K | 1,130,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-23 | 2023-02-27 | 22,590 | — | $0 | 22,590 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-23 | 2023-02-27 | 22,590 | — | $0 | 1,122,899 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 22,895 | $46.54 | $1.07M | 1,105,262 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 2,200 | $47.35 | $104.2K | 1,103,062 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 2,502 | $48.70 | $121.8K | 1,100,560 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 251 | $49.60 | $12.4K | 1,100,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-18 | 2023-02-22 | 27,848 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-18 | 2023-02-22 | 27,848 | — | $0 | 1,128,157 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-12-13 | 2022-12-15 | 33,083 | $55.00 | $1.82M | 1,100,309 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 50,167 | — | $0 | 50,167 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 61,696 | — | $0 | 61,696 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-03-09 | 2022-03-10 | 38,925 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-03-09 | 2022-03-10 | 38,925 | $2.84 | $110.5K | 1,133,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 100 | $50.92 | $5.1K | 1,094,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 11,240 | $51.61 | $580.1K | 1,094,567 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 11,249 | $52.35 | $588.9K | 1,105,807 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-23 | 2022-02-25 | 22,589 | — | $0 | 45,180 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-23 | 2022-02-25 | 22,589 | — | $0 | 1,117,056 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 15,180 | $55.73 | $846.0K | 1,107,134 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 12,667 | $54.98 | $696.4K | 1,094,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-18 | 2022-02-23 | 27,847 | — | $0 | 27,848 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-18 | 2022-02-23 | 27,847 | — | $0 | 1,122,314 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 27,138 | $40.80 | $1.11M | 1,103,421 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 5,804 | $41.72 | $242.1K | 1,130,559 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 8,954 | $40.10 | $359.1K | 1,094,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-01-08 | 2022-01-11 | 41,896 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-01-08 | 2022-01-11 | 41,896 | — | $0 | 1,136,363 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-18 | 2021-10-18 | 8,192 | $40.00 | $327.7K | 1,094,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-10-15 | 2021-10-18 | 1,075 | — | $0 | 38,925 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-15 | 2021-10-18 | 40,392 | $40.00 | $1.62M | 1,101,584 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-10-15 | 2021-10-18 | 1,075 | $2.84 | $3.1K | 1,102,659 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-14 | 2021-10-18 | 1,416 | $40.00 | $56.6K | 1,141,976 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-08-23 | 2021-08-24 | 10,000 | — | $0 | 40,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-08-23 | 2021-08-24 | 10,000 | $2.84 | $28.4K | 1,143,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 67,769 | — | $0 | 67,769 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 53,471 | — | $0 | 53,471 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 3,100 | $38.91 | $120.6K | 1,133,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 24,747 | $39.27 | $971.8K | 1,136,492 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-02-18 | 2021-02-22 | 27,847 | — | $0 | 55,695 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-02-18 | 2021-02-22 | 27,847 | — | $0 | 1,161,239 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-11 | 2021-01-12 | 4,585 | $31.64 | $145.1K | 1,133,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-11 | 2021-01-12 | 37,311 | $32.06 | $1.20M | 1,137,977 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-01-08 | 2021-01-12 | 41,896 | — | $0 | 41,896 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-01-08 | 2021-01-12 | 41,896 | — | $0 | 1,175,288 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 27,913 | $31.39 | $876.2K | 1,153,820 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 11,200 | $31.39 | $351.6K | 1,136,192 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 2,800 | $30.94 | $86.6K | 1,133,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 6,428 | $30.94 | $198.9K | 1,147,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-01-03 | 2021-01-05 | 34,341 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-01-03 | 2021-01-05 | 34,341 | — | $0 | 1,181,733 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-12-18 | 2020-12-21 | 34,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-12-18 | 2020-12-21 | 34,000 | $2.74 | $93.2K | 1,147,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-11-10 | 2020-11-12 | 19,131 | $26.91 | $514.8K | 1,113,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-11-10 | 2020-11-12 | 30,869 | $25.99 | $802.3K | 1,132,523 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-11-04 | 2020-11-06 | 50,000 | $25.00 | $1.25M | 1,163,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 83,542 | — | $0 | 83,542 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 66,886 | — | $0 | 66,886 | SEC↗ |
| ITCI Intra-Cellular Therapies, | J Other | 2020-01-24 | 2020-01-28 | 9,323 | $23.61 | $220.1K | 1,213,392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-01-24 | 2020-01-28 | 18,008 | — | $0 | 1,222,715 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-09 | 2020-01-10 | 41,895 | $26.16 | $1.10M | 1,204,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-08 | 2020-01-08 | 41,895 | — | $0 | 83,792 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-08 | 2020-01-08 | 16,000 | — | $0 | 34,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-08 | 2020-01-08 | 44,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-08 | 2020-01-08 | 16,000 | $2.74 | $43.8K | 1,246,602 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-08 | 2020-01-08 | 41,895 | — | $0 | 1,186,602 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-08 | 2020-01-08 | 44,000 | $2.74 | $120.6K | 1,230,602 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-06 | 2020-01-08 | 7,939 | $29.78 | $236.4K | 1,182,366 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-06 | 2020-01-08 | 37,659 | $30.39 | $1.14M | 1,144,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-03 | 2020-01-03 | 11,258 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-03 | 2020-01-03 | 34,340 | — | $0 | 34,341 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-03 | 2020-01-03 | 11,258 | — | $0 | 1,155,965 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-03 | 2020-01-03 | 34,340 | — | $0 | 1,190,305 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 3,700 | $31.85 | $117.8K | 1,158,485 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 10,722 | $32.43 | $347.7K | 1,147,763 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 3,000 | $33.25 | $99.8K | 1,144,763 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 56 | $34.30 | $1.9K | 1,144,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-12-31 | 2020-01-03 | 6,000 | — | $0 | 44,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-12-31 | 2020-01-03 | 6,000 | $2.74 | $16.4K | 1,162,185 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-12-31 | 2020-01-03 | 17,478 | — | $0 | 1,156,185 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-08 | 172,697 | — | $0 | 172,697 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-08 | 125,687 | — | $0 | 125,687 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-07 | 2019-01-08 | 6,604 | $12.43 | $82.1K | 1,138,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-04 | 2019-01-08 | 6,604 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-04 | 2019-01-08 | 38,059 | $11.38 | $433.1K | 1,152,850 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-04 | 2019-01-08 | 6,604 | — | $0 | 1,190,909 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-04 | 2019-01-08 | 7,539 | $11.82 | $89.1K | 1,145,311 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-03 | 2019-01-03 | 11,258 | — | $0 | 11,258 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-03 | 2019-01-03 | 34,340 | — | $0 | 68,681 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-03 | 2019-01-03 | 11,258 | — | $0 | 1,149,965 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-03 | 2019-01-03 | 34,340 | — | $0 | 1,184,305 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-02 | 2019-01-03 | 17,478 | $11.09 | $193.8K | 1,138,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-12-31 | 2019-01-03 | 17,478 | — | $0 | 1,156,185 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2018-12-10 | 2018-12-11 | 50,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2018-12-10 | 2018-12-11 | 50,000 | $1.50 | $75.0K | 1,138,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2018-01-08 | 2018-01-10 | 6,604 | $17.48 | $115.4K | 1,088,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2018-01-05 | 2018-01-05 | 11,257 | $17.08 | $192.3K | 1,095,311 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2018-01-04 | 2018-01-05 | 6,604 | — | $0 | 6,604 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2018-01-04 | 2018-01-05 | 6,604 | — | $0 | 1,106,568 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2018-01-03 | 2018-01-05 | 11,257 | — | $0 | 22,516 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-01-03 | 2018-01-05 | 103,021 | — | $0 | 103,021 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-01-03 | 2018-01-05 | 138,473 | — | $0 | 138,473 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2018-01-03 | 2018-01-05 | 11,257 | — | $0 | 1,099,964 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2017-10-30 | 2017-11-01 | 18,750 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2017-10-30 | 2017-11-01 | 18,750 | $15.75 | $295.3K | 1,088,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2017-10-30 | 2017-11-01 | 18,750 | $1.50 | $28.1K | 1,107,457 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2017-01-05 | 2017-01-09 | 4,081 | $16.55 | $67.5K | 1,088,707 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2017-01-04 | 2017-01-05 | 6,603 | — | $0 | 13,208 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2017-01-04 | 2017-01-05 | 6,603 | — | $0 | 1,092,788 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-01-03 | 2017-01-05 | 135,399 | — | $0 | 135,399 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-01-03 | 2017-01-05 | 33,773 | — | $0 | 33,773 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2023-07-07 | 86,003 | — | $0 | 86,003 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2016-01-06 | 83,528 | — | $0 | 83,528 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2016-01-06 | 19,811 | — | $0 | 19,811 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2015-12-11 | 2015-12-15 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2015-12-11 | 2015-12-15 | 25,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2015-12-11 | 2015-12-15 | 25,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2015-12-11 | 2015-12-15 | 1,800 | $55.08 | $99.1K | 1,086,185 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2015-12-11 | 2015-12-15 | 19,654 | $54.24 | $1.07M | 1,087,985 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2015-12-11 | 2015-12-15 | 30,046 | $53.56 | $1.61M | 1,107,639 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2015-12-11 | 2015-12-15 | 18,750 | $1.50 | $28.1K | 1,137,685 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2015-12-11 | 2015-12-15 | 25,000 | $1.36 | $34.0K | 1,118,935 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2015-12-11 | 2015-12-15 | 25,000 | $0.60 | $15.0K | 1,093,935 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2015-01-02 | 2015-01-06 | 228,380 | — | $0 | 228,380 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2014-11-28 | 2014-11-28 | 35,000 | $14.75 | $516.3K | 1,068,935 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2014-11-25 | 2014-11-28 | 50,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2014-11-25 | 2014-11-28 | 50,000 | $0.50 | $25.0K | 1,103,935 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2014-06-30 | 2014-07-02 | 200,000 | — | $0 | 200,000 | SEC↗ |